Jessica Pasley Archive — Page 1 of 56

September 17, 2026

An unexpected detour leads patient transporter Jon Cook to a Credo Award celebration

Known for supporting patients, families and colleagues alike, Cook brings heart and hustle to every shift.

Since 1981, Scholastic Book Fairs have been a much-loved pop-up tradition around the country. Scholastic partners with schools nationwide to host over 100,000 events annually, providing 30 million students and families with access to thousands of affordable books. (Submitted photo)
September 16, 2026

Scholastic Book Fair set to arrive at Monroe Carell Jr. Children’s Hospital at Vanderbilt for the first time

Since 1981, Scholastic Book Fairs have been a much-loved pop-up tradition around the country. Scholastic partners with schools nationwide to host over 100,000 events annually, providing 30 million students and families with access to thousands of affordable books.

September 1, 2026

The Case of the Missing Statue: Red Paper Dolls vanish for a secret makeover!

The nearly 9-foot-tall, 1,500-pound, aluminum sculpture has served as the logo for the hospital since 1971, and now those iconic paper dolls are getting a dose of rehab therapy. Watch a timelapse video of the removal!

(iStock)
August 26, 2026

Duchenne muscular dystrophy patients are focus of GLP-1 therapy for obesity study

The study will begin enrolling eligible patients in September. Thirty participants, ages 12 and older, will be randomized to receive either a placebo or the GLP-1 receptor agonist semaglutide.

August 18, 2026

As schedules change, health care advocates encourage back seat second looks to prevent hot car deaths

It only takes 10 minutes for the temperature inside a vehicle to rise 19 degrees and continue to rise. Even on cooler days closer to 70 degrees, children can experience vehicular heatstroke.

August 18, 2026

Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling

The study, Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder (TAB), is a double-blind, randomized, placebo-controlled trial conducted through the National Institute on Drug Abuse’s Clinical Trials Network.